Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

98.050
+2.1502.24%
Volume:16.81M
Turnover:1.64B
Market Cap:171.10B
PE:208.62
High:99.350
Open:95.150
Low:94.800
Close:95.900
52wk High:112.700
52wk Low:69.550
Shares:1.75B
HK Float Shares:1.75B
Volume Ratio:1.98
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.470
ROE:7.01%
ROA:2.23%
PB:7.06
PE(LYR):208.62
PS:9.32

Loading ...

China's CStone Pharmaceuticals H1 Revenue Soars on Drug Sales

Reuters
·
Aug 27

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

Biocytogen Pharmaceuticals H1 Revenue up 51.6%

Reuters
·
Aug 27

Jefferies Boosts INNOVENT BIO Target to HK$125, Maintains Buy Rating

Stock News
·
Aug 27

Innovent Biologics' Outlicensing Drug Deals Could Remain Key Share-Price Driver

Dow Jones
·
Aug 27

China's Drug Regulator Accepts Novo Nordisk's Application for Oral Wegovy

Reuters
·
Aug 27

Movement Alert|INNOVENT BIO Declines 3.1% in Regular Trading, Profit-Taking Follows Record High After Earnings Beat

Market Focus
·
Aug 27

China's Jiangsu Says it Will Support Pharmaceutical Firms' Global M&A, Licensing

Reuters
·
Aug 26

Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes

Reuters
·
Aug 26

Southbound Capital Insights: Net Buying Hits HK$453 Million, Innovent Bio Faces Heavy Selling After Earnings Surge

Stock News
·
Aug 26

CICC Maintains Outperform Rating on Innovent Biologics with Target Price Set at HK$118.30

Deep News
·
Aug 26

-BUZZ-China's Innovent Biologics Hits All-Time High on H1 Growth

Reuters
·
Aug 26

Hong Kong Biotech Sector Surges Again as Innovative Drug Stocks Lead Gains, INNOVENT BIO Hits Record High

Deep News
·
Aug 26

China, HK Stocks Track Global Tech Rebound; Gold Miners Rally

Reuters
·
Aug 26

Hong Kong's SSY Group H1 Profit Rises on Infusion Solutions Growth

Reuters
·
Aug 26

Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength

Reuters
·
Aug 26

Mainland Benchmarks Edge Higher in Morning Trade; Nonferrous Metals and Brokerages Lead While Optical Modules Retreat; Hang Seng and Tech Index Climb Over 1% on Biotech Surge

Deep News
·
Aug 26

Movement Alert|INNOVENT BIO Rises 8.89% in Regular Trading, H1 Net Profit Surges 50% with 2030 Revenue Target of RMB 35-40 Billion

Market Focus
·
Aug 26

INNOVENT BIO Surges 6% on Robust H1 Earnings, Sets Ambitious 2030 Revenue Target

Stock News
·
Aug 26

JPMorgan Raises Stake in Innovent Bio With HK$241M Share Purchase

Deep News
·
Aug 26